Reports
Reports
Sale
The global defibrillator market was valued at USD 9.5 billion in 2023, driven by the increasing cases of cardiovascular diseases and advancements in defibrillator technology across the globe. The market is expected to grow at a CAGR of 5.12% during the forecast period of 2024-2032, with the values likely to reach USD 14.9 billion by 2032.
A defibrillator is a life-saving medical device that can be used to administer a dose of electric current to the heart. Defibrillation treatment is given for life-threatening cardiac arrhythmias to restore a normal heartbeat. Immediate defibrillation can increase the chances of survival of a patient undergoing sudden cardiac arrest. The increasing focus on improving public access to portable automated external defibrillators (AEDs) is likely to fuel the market demand. The high prevalence of cardiovascular diseases and the increasing aging population are resulting in the wider adoption of advanced defibrillators in hospitals, clinics, and public places. Several factors such as supportive regulatory policies, rising healthcare expenditures, and the increasing advancements in defibrillator technology are poised to shape the market landscape.
Increasing Prevalence of Cardiovascular Diseases to Affect the Market Landscape Significantly
Recent data indicates that cardiovascular disease is the leading cause of death for both men and women worldwide. Out of the overall population of 8 billion in 2023, nearly 620 million individuals are affected by health and circulatory disease which accounts for 1 in 13 individuals living with a heart or circulatory condition globally. The rising burden of cardiovascular diseases, including heart attacks and arrhythmias is a major growth driver of the market. Further, the rising aging population more prone to developing the condition is poised to fuel market demand in the coming years.
Rise in FDA Approvals Poised to Fuel Defibrillator Market Demand
In October 2023, Medtronic announced that the United States Food and Drug Administration (FDA) granted approval to its extravascular defibrillator Aurora EV-ICD™ system for treating abnormal heart rhythms and preventing sudden cardiac arrest. In contrast to conventional implantable cardioverter defibrillators, the placement of leads in Aurora EV-ICD happens outside the heart rather than inside the heart and veins. This less-invasive device reduces the risk of complications such as fractures and insulation failure and is the first defibrillation system that can manage dangerously fast heart rhythms with the lead placement under the breastbone. The rise in regulatory approvals of such safe and effective implantable cardioverter defibrillator (ICD) technology is likely to bolster the market growth.
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
Rising Focus on Portable and User-Friendly Devices
The market is witnessing an increased demand for portable automated external defibrillators (AEDs) which can be attributed to their ease of use and effectiveness in emergency situations. These user-friendly can be handled by non-medical personnel to administer life-saving shocks during emergencies.
Technological Advancements
Many device manufacturing companies are integrating artificial intelligence (AI) technologies into defibrillators to make them more efficient and user-friendly. Moreover, there is a growing adoption of advanced wearable cardioverter defibrillators (WCDs), which provide continuous monitoring and immediate response to cardiac events.
Growth in Funding and Grants
The defibrillator market value is influenced by the increased funding and grants for the placement of automated external defibrillators in public places by both the government and private organizations. Further, increased investment in research activities aimed at advancing defibrillation technologies are poised to support market growth.
Increased Public Access Initiatives
One of the major trends is the increased public access initiatives to place automated external defibrillators in public spaces such as airports, schools, shopping malls, and others. The rising availability of these devices ensures that immediate response can be given to the patient in case of cardiac emergencies.
Market Breakup by Product
Market Breakup by Patient
Market Breakup by End User
Market Breakup by Region
Market Segmentation Based on Products is Anticipated to Witness Substantial Growth
Based on the product, the market is segmented into implantable cardioverter defibrillators, subcutaneous ICDs, and external defibrillators. The implantable cardioverter defibrillator (ICD) segment covers a considerable market share due to its proven efficacy in preventing sudden cardiac death. The increasing awareness about the need for early intervention for cardiac issues and the growing aging population prone to heart complications are some of the factors propelling the demand for implantable cardioverter defibrillators. The subcutaneous implantable cardioverter defibrillator segment is also expected to grow in the forecast period, owing to its minimally invasive nature and no intravenous lead placement, thereby reducing the risk of infections.
Based on the region, North America holds the largest market share for defibrillators driven by the high incidence of cardiovascular diseases, heightened awareness regarding cardiac health, and the presence of a well-established healthcare infrastructure. Moreover, the supportive regulatory policies in North American countries like the United States and Canada ensure the swift approval and adoption of new defibrillation technologies.
Asia Pacific is projected to hold a substantial defibrillator market value, which can be attributed to increased government initiatives aimed at improving healthcare infrastructure and access to advanced medical devices. With heart issues becoming common, particularly in countries such as China, India, and Japan, the market demand for defibrillators is set to surge in the region in the forecast period.
The key features of the market report comprise the patent analysis, grant analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:
Medtronic PLC
Headquartered in Dublin, Ireland, this global healthcare technology company is one of the leading players in the market. Medtronic is known for its advanced implantable cardioverter defibrillators (ICDs) and external defibrillators and often engages in strategic acquisitions and partnerships to strengthen its market position.
Stryker Corporation
Based in Michigan, United States, Stryker Corporation is a multinational medical technologies company that is recognized for its robust distribution network. The company invests heavily in R&D to improve the functionality of defibrillators and enhance the accessibility of these life-saving devices.
Koninklijke Philips N.V.
Multinational conglomerate corporation Koninklijke Philips N.V., headquartered in Amsterdam, Netherlands, manufactures medical systems including defibrillation devices. Philips automated external defibrillator (AED) and Philips HeartStart AEDs are some of the popular products in the market.
Other key players in the market include Boston Scientific Corporation, Nihon Kohden Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Biotronik Medical Devices India Pvt. Ltd., MicroPort Scientific Corporation, and Schiller Healthcare India Pvt., among others.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by Patient |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Defibrillator Market Overview
3.1 Global Defibrillator Market Historical Value (2017-2023)
3.2 Global Defibrillator Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Defibrillator Market Landscape*
5.1 Global Defibrillator Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Defibrillator Market: Product Landscape
5.2.1 Analysis by Product
5.2.2 Analysis by Patient Type
6 Global Defibrillator Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Defibrillator Market Segmentation (2017-2032)
7.1 Global Defibrillator Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Implantable Cardioverter Defibrillator
7.1.3 Subcutaneous ICD
7.1.4 External Defibrillator
7.2 Global Defibrillator Market (2017-2032) by Patient
7.2.1 Market Overview
7.2.2 Adult
7.2.3 Pediatric
7.3 Global Defibrillator Market (2017-2032) by End User
7.3.1 Market Overview
7.3.2 Hospitals
7.3.3 Specialty Clinics
7.3.4 Home Care Settings
7.3.5 Others
7.4 Global Defibrillator Market (2017-2032) by Region
7.4.1 Market Overview
7.4.2 North America
7.4.3 Europe
7.4.4 Asia Pacific
7.4.5 Latin America
7.4.6 Middle East and Africa
8 North America Defibrillator Market (2017-2032)
8.1 North America Defibrillator Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Implantable Cardioverter Defibrillator
8.1.3 Subcutaneous ICD
8.1.4 External Defibrillator
8.2 North America Defibrillator Market (2017-2032) by Patient
8.2.1 Market Overview
8.2.2 Adult
8.2.3 Pediatric
8.3 North America Defibrillator Market (2017-2032) by End User
8.3.1 Market Overview
8.3.2 Hospitals
8.3.3 Specialty Clinics
8.3.4 Home Care Settings
8.3.5 Others
8.4 North America Defibrillator Market (2017-2032) by Country
8.4.1 United States of America
8.4.2 Canada
9 Europe Defibrillator Market (2017-2032)
9.1 Europe Defibrillator Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Implantable Cardioverter Defibrillator
9.1.3 Subcutaneous ICD
9.1.4 External Defibrillator
9.2 Europe Defibrillator Market (2017-2032) by Patient
9.2.1 Market Overview
9.2.2 Adult
9.2.3 Pediatric
9.3 Europe Defibrillator Market (2017-2032) by End User
9.3.1 Market Overview
9.3.2 Hospitals
9.3.3 Specialty Clinics
9.3.4 Home Care Settings
9.3.5 Others
9.4 Europe Defibrillator Market (2017-2032) by Country
9.4.1 United Kingdom
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Others
10 Asia Pacific Defibrillator Market (2017-2032)
10.1 Asia Pacific Defibrillator Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Implantable Cardioverter Defibrillator
10.1.3 Subcutaneous ICD
10.1.4 External Defibrillator
10.2 Asia Pacific Defibrillator Market (2017-2032) by Patient
10.2.1 Market Overview
10.2.2 Adult
10.2.3 Pediatric
10.3 Asia Pacific Defibrillator Market (2017-2032) by End User
10.3.1 Market Overview
10.3.2 Hospitals
10.3.3 Specialty Clinics
10.3.4 Home Care Settings
10.3.5 Others
10.4 Asia Pacific Defibrillator Market (2017-2032) by Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 ASEAN
10.4.5 Australia
10.4.6 Others
11 Latin America Defibrillator Market (2017-2032)
11.1 Latin America Defibrillator Market (2017-2032) by Product
11.1.1 Market Overview
11.1.2 Implantable Cardioverter Defibrillator
11.1.3 Subcutaneous ICD
11.1.4 External Defibrillator
11.2 Latin America Defibrillator Market (2017-2032) by Patient
11.2.1 Market Overview
11.2.2 Adult
11.2.3 Pediatric
11.3 Latin America Defibrillator Market (2017-2032) by End User
11.3.1 Market Overview
11.3.2 Hospitals
11.3.3 Specialty Clinics
11.3.4 Home Care Settings
11.3.5 Others
11.4 Latin America Defibrillator Market (2017-2032) by Country
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Mexico
11.4.4 Others
12 Middle East and Africa Defibrillator Market (2017-2032)
12.1 Middle East and Africa Defibrillator Market (2017-2032) by Product
12.1.1 Market Overview
12.1.2 Implantable Cardioverter Defibrillator
12.1.3 Subcutaneous ICD
12.1.4 External Defibrillator
12.2 Middle East and Africa Defibrillator Market (2017-2032) by Patient
12.2.1 Market Overview
12.2.2 Adult
12.2.3 Pediatric
12.3 Middle East and Africa Defibrillator Market (2017-2032) by End User
12.3.1 Market Overview
12.3.2 Hospitals
12.3.3 Specialty Clinics
12.3.4 Home Care Settings
12.3.5 Others
12.4 Middle East and Africa Defibrillator Market (2017-2032) by Country
12.4.1 Saudi Arabia
12.4.2 United Arab Emirates
12.4.3 Nigeria
12.4.4 South Africa
12.4.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Patent Analysis
15.1 Analysis by Type of Patent
15.2 Analysis by Publication Year
15.3 Analysis by Issuing Authority
15.4 Analysis by Patent Age
15.5 Analysis by CPC Analysis
15.6 Analysis by Patent Valuation
15.7 Analysis by Key Players
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Strategic Initiatives
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Market Share Analysis, By Region (Top 5 Companies)
18.1.1 Market Share Analysis: Global
18.1.2 Market Share Analysis: North America
18.1.3 Market Share Analysis: Europe
18.1.4 Market Share Analysis: Asia Pacific
18.1.5 Market Share Analysis: Others
18.2 Medtronic PLC.
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Company News and Development
18.2.5 Certifications
18.3 Stryker Corporation
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Company News and Development
18.3.5 Certifications
18.4 Koninklijke Philips N.V.
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Company News and Development
18.4.5 Certifications
18.5 Boston Scientific Corporation
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Company News and Development
18.5.5 Certifications
18.6 Nihon Kohden Corporation
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Company News and Development
18.6.5 Certifications
18.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Company News and Development
18.7.5 Certifications
18.8 Biotronik Medical Devices India Pvt. Ltd.
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Company News and Development
18.8.5 Certifications
18.9 MicroPort Scientific Corporation
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic
18.9.4 Company News and Development
18.9.5 Certifications
18.10 Schiller Healthcare India Pvt.
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Company News and Development
18.10.5 Certifications
19 Global Defibrillator Market – Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.